Laser breakthrough speeds tissue imaging & Six-month HIV prevention shot rollout - News (Apr 28, 2026)

Starting in science and medicine: researchers at MIT report a result that flips a long-held assumption about powerful lasers in multimode optical fibers. Instead of becoming increasingly scrambled at higher power, the light can—under the right conditions—self-organize into a tightly focused beam. The practical payoff is big: the team used it for multiphoton imaging and produced 3D, cellular-level views of a human blood–brain barrier model far faster than typical methods, while keeping similar detail. Beyond the wow factor, it could make drug testing in engineered tissues quicker and more informative, potentially reducing reliance on animal experiments in early research.

Next, a major prevention development in public health: South Africa’s Health Department is preparing a phased rollout of lenacapivir, a long-acting HIV prevention injection given once every six months. Clinicians and advocates say the key advantage is straightforward—fewer dosing moments means fewer missed doses, which is a persistent challenge with daily pills. Officials also stress a reality check: it’s not a replacement for other protection, because it doesn’t prevent other sexually transmitted infections. Early access will be limited, starting at a relatively small number of sites in high-burden districts and focusing on people at highest risk, while supply and funding uncertainties could shape how quickly it reaches wider public and private care.

Staying with biotech, Intellia Therapeutics says its one-time CRISPR-based treatment for hereditary angioedema hit its main target in a pivotal Phase 3 trial. Hereditary angioedema can cause severe swelling attacks that become dangerous fast, and the company reports a steep reduction in attack rates versus placebo, with many patients attack-free at six months without additional preventive therapy. It’s also being watched as a milestone: one of the clearest late-stage successes for gene editing delivered inside the body, not just via cells edited outside the body. Regulators will still scrutinize safety closely—especially given heightened attention after liver-toxicity concerns in a different Intellia program—but the company is already moving through the FDA submission process with an eye on a 2027 U.S. launch if approved.

Now to the shifting landscape in artificial intelligence governance and business strategy. OpenAI has released an updated “Our Principles” document that signals a change in tone compared with its earlier era. The 2026 version frames progress less as a race to a single finish line—AGI—and more as an ongoing societal process of integrating more capable systems step by step. It leans heavily on broad access and resisting concentration of power, while also calling for more collaboration with governments and international bodies to manage risks before pushing into higher capability levels. Notably, it also drops an older commitment that OpenAI might step aside if another project looked more safety-aligned near an AGI threshold—replacing that idea with a promise of transparency about how its own rules might evolve as its influence grows.

Related, Microsoft and OpenAI have again reworked their partnership—and this time it’s a foundational change. The long-disputed “AGI clause” is gone, removing special conditions that would have kicked in if artificial general intelligence were declared. Microsoft remains OpenAI’s primary cloud partner and still has strong commercial advantages, but OpenAI now has more freedom to run and sell products across other cloud providers if Microsoft can’t or won’t meet certain needs. The adjustment also reduces pressure around publicly labeling any breakthrough as “AGI,” and it signals a relationship that’s becoming less exclusive and more openly commercial—especially as OpenAI seeks flexibility, scale, and profitability.

That business shift is landing in a market already fired up about AI. Wall Street strategists say confidence has returned to the so-called AI trade, with chip stocks leading and major indexes hovering at record highs. Nvidia briefly touched a staggering valuation milestone, and Intel posted its biggest one-day jump in decades, feeding the narrative that infrastructure spending for advanced AI systems is still accelerating. The big question isn’t whether demand is real—it’s how long the spending wave can run before investors start arguing more seriously about a peak. For now, the rally is also reshaping how people think about the semiconductor sector’s typical boom-and-bust cycles.

Turning to energy and geopolitics, Europe is still absorbing the shock from the closure of the Strait of Hormuz after the Iran war halted tanker traffic in early March. With Persian Gulf oil and major LNG flows disrupted, the episode has underscored how quickly energy security can become an economic and political vulnerability. The European Union is responding by doubling down on diversification: renewables are now a central pillar of electricity supply, nuclear remains a major contributor, and policy is pushing alternative gas sourcing, biomethane, and green hydrogen. What’s interesting here is the blend of urgency and long-term planning—Europe is trying to protect reliability now while also locking in a system that’s less exposed to chokepoints and conflict.

Against that backdrop, a notable climate diplomacy experiment is underway in Santa Marta, Colombia: the world’s first dedicated conference focused specifically on phasing out fossil fuels. Dozens of countries are participating, with the goal of moving beyond broad emissions promises to practical negotiations on winding down coal, oil, and gas production in a “just, orderly, and equitable” way. The timing is pointed—an oil shock tied to the Hormuz disruption is a live reminder that fossil dependence is not only a climate issue, but also a security and price-stability issue. Organizers want this to become a recurring process, which could matter for markets if phaseout discussions start translating into durable policy signals.

And finally, a reminder of the human cost behind big technology decisions. Pope Leo XIV marked the 40th anniversary of the Chernobyl disaster with a call for atomic energy to be used only for peaceful purposes, describing the 1986 explosion as a lasting warning about the dangers that can accompany powerful technologies. Chernobyl remains the worst civilian nuclear accident in history, and its legacy is still contested in numbers but undeniable in impact—from contaminated land to long-term health effects and the enormous sacrifices of cleanup workers. The Pope’s message lands as multiple regions revisit nuclear power’s role in energy security, underscoring that public trust hinges on responsibility as much as on capacity.